Sat Kartar Life Limited Approves Significant Funding Rounds and Stake Acquisition
Sat Kartar Life Limited, formerly known as Sat Kartar Shopping Limited, announced key corporate decisions following its Board meeting on April 18, 2026. The board approved plans to raise capital through two preferential issues and to significantly increase its stake in its subsidiary, Plantomed Nutraceuticals Private Limited. The board noted that the proposed fund raise is a strategic move designed to strengthen the company's integrated healthcare platform, which combines Ayurveda products with hospital-based care, aiming for scalable growth and enhanced long-term value for stakeholders.Fundraising through Preferential Issuance
The company approved two distinct funding mechanisms via preferential issues.1. Equity Shares Preferential Issue
The company plans to issue up to 50,400 fully paid-up Equity Shares at a face value of ₹ 10.00 each. These shares will be issued at a price of ₹ 172, which includes a premium of ₹ 162. The total aggregate amount to be raised through this issue is up to ₹ 86,68,800.
The proposed allottees for the Equity Shares are:
* Viney Growth Fund (Non-promoter category)
2. Convertible Warrants Preferential Issue
In addition, the board approved the issuance of up to 27,74,400 Convertible Warrants. Each warrant is redeemable for one fully paid-up Equity Share of the Company, priced at ₹ 172, including a premium of ₹ 162. The aggregate amount targeted from this issuance is up to ₹ 47,71,96,800.
These warrants are being offered to multiple non-promoter category proposed allottees. The details of the warrants allotment and consideration are presented below:
| Name of the Proposed Allottee | Convertible Warrants Allotted | Consideration (in ₹) |
|---|---|---|
| Lighthouse Canton Special Opportunities Fund - I | 1,00,000 | 1,72,00,000.00 |
| Viney Growth Fund | 50,400 | 86,68,800.00 |
| Jamsaria Family Trust | 2,91,200 | 5,00,86,400.00 |
| Ravi Kumar | 6,98,400 | 12,01,24,800.00 |
| Kawaljit Singh | 3,34,400 | 5,75,16,800.00 |
| Bimal Suri | 2,91,200 | 5,00,86,400.00 |
| SLV Finvest Limited | 2,91,200 | 5,00,86,400.00 |
| Lurk Estate Private Limited | 2,04,000 | 3,50,88,000.00 |
| Vanilla Consultants | 1,15,200 | 1,98,14,400.00 |
| Vandana Minhas | 1,00,000 | 1,72,00,000.00 |
| Anita Jain | 87,200 | 1,49,98,400.00 |
| Arun Sethi | 87,200 | 1,49,98,400.00 |
| Divine Comex Enterprises Private Limited | 79,200 | 1,36,22,400.00 |
| Inderjeet Singh | 24,800 | 42,65,600.00 |
| EPSON Project Private Limited | 20,000 | 34,40,000.00 |
| Total | 27,74,400 | 47,71,96,800.00 |
The board noted that the proposed issuance of securities will not result in any change in control or management of the company.
Path to Wholly Owned Subsidiary Status
A third major approval concerns the investment in the subsidiary company, Plantomed Nutraceuticals Private Limited. The board approved the further acquisition of an additional 24% stake, which is expected to make Plantomed Nutraceuticals Private Limited a wholly owned subsidiary of Sat Kartar Life Limited.The details of this acquisition are summarized as follows:
| Detail | Description |
|---|---|
| Target Entity | Plantomed Neutraceuticals Private Limited |
| Acquisition Status | Transaction results in the change from subsidiary to wholly owned subsidiary. |
| Object and Effects | Enables the company to gain 100% control, aiding brand consolidation and product expansion for Sat Kartar Life Limited. |
| Nature of Consideration | Cash Consideration |
| Cost of Acquisition | ₹ 1,21,00,000/- (subject to final adjustments) |
| Expected Completion | By May 15, 2026 |
Corporate Governance and Investor Meeting
The company also approved convening an Extra Ordinary General Meeting (EGM) of shareholders for May 13, 2026, at 10:00 A.M. The board fixed May 06, 2026, as the record date for determining which shareholders are eligible to vote at the EGM regarding the preferential issue.The National Stock Exchange of India Limited services the company under the symbol SATKARTAR.
Company Background
Sat Kartar Life Limited is primarily involved in Ayurveda, Unani, nutraceuticals, and pharmaceutical preparations. It operates as an Ayurveda healthcare company committed to providing natural wellness solutions for specific therapeutic areas and general lifestyle products, aimed at promoting a healthier lifestyle. The company was incorporated on March 19, 2023, and currently operates in India.The turnover figures for the last two fiscal years stand as:
| Fiscal Year | Turnover |
|---|---|
| 23-24 | 1,94,98,266 |
| 24-25 | 73,26,391 |
SATKARTAR Stock Price Movement
On Friday, Sat Kartar Shopping Limited shares slipped by 0.88% to close at ₹185.10. The stock traded on a volume of 28,800 shares, settling below its previous day's closing price of ₹186.75.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: